News As Brexit trigger nears, UK pharma prepares for different sc... AstraZeneca chief considers two possible scenarios for post-Brexit regulation
News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
Views & Analysis ‘Quickie divorce’ Brexit not an option for medicines, says U... The UK government wants a 'bespoke' deal for pharma - but the EU has other ideas.
News UK could seek ‘transitional deal’ to cushion Brexit PM also promises corporation tax cuts and innovation investment
Views & Analysis What doctors say about Theresa May’s reappointment of Jeremy... Reactions of healthcare professionals to Jeremy Hunt staying as Health Secretary.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
